Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shapiro

Showing results (891-900 of 1,171) with videos related to

Pageof 118
Sort By:
International Journal of Nephrology and Renovascular Disease|April 10, 2019
Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) studyTian Chen, Pamela Brewster, Katherine R Tuttle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitorRobert I Haddad, Lisa J Weinstein, Tad J Wieczorek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, Geoffrey I Shapiro, Roger B Cohen, et al.
Critical Care Medicine|March 4, 2017
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) StudyPhilipp Schuetz, Robert Birkhahn, Robert Sherwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumoursD S Boss, G K Schwartz, M R Middleton, et al.
Frontiers in Cardiovascular Medicine|August 19, 2024
CD36 restricts lipid-associated macrophages accumulation in white adipose tissues during atherogenesisVaya Chen, Jue Zhang, Jackie Chang, et al.
Cancer Research|June 17, 2024
Single-Stranded DNA Gap Accumulation Is a Functional Biomarker for USP1 Inhibitor SensitivityAlexandre A da Costa, Ozge Somuncu, Ramya Ravindranathan, et al.
Molecular Cancer Therapeutics|May 7, 2020
Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734Chevaun D Morrison-Smith, Tatiana M Knox, Ivona Filic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001A T Shaw, G J Riely, Y-J Bang, et al.
Shock (Augusta, Ga.)|July 1, 2014
Age-related differences in biomarkers of acute inflammation during hospitalization for sepsisAdit A Ginde, Patrick J Blatchford, Stephen Trzeciak, et al.
Pageof 118

Showing results (891-900 of 1,171) with videos related to

Sort By:
Pageof 118
International Journal of Nephrology and Renovascular Disease|April 10, 2019
Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) studyTian Chen, Pamela Brewster, Katherine R Tuttle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitorRobert I Haddad, Lisa J Weinstein, Tad J Wieczorek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, Geoffrey I Shapiro, Roger B Cohen, et al.
Critical Care Medicine|March 4, 2017
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) StudyPhilipp Schuetz, Robert Birkhahn, Robert Sherwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumoursD S Boss, G K Schwartz, M R Middleton, et al.
Frontiers in Cardiovascular Medicine|August 19, 2024
CD36 restricts lipid-associated macrophages accumulation in white adipose tissues during atherogenesisVaya Chen, Jue Zhang, Jackie Chang, et al.
Cancer Research|June 17, 2024
Single-Stranded DNA Gap Accumulation Is a Functional Biomarker for USP1 Inhibitor SensitivityAlexandre A da Costa, Ozge Somuncu, Ramya Ravindranathan, et al.
Molecular Cancer Therapeutics|May 7, 2020
Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734Chevaun D Morrison-Smith, Tatiana M Knox, Ivona Filic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001A T Shaw, G J Riely, Y-J Bang, et al.
Shock (Augusta, Ga.)|July 1, 2014
Age-related differences in biomarkers of acute inflammation during hospitalization for sepsisAdit A Ginde, Patrick J Blatchford, Stephen Trzeciak, et al.
Pageof 118